Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. (PROVENT): Worth Considering for any Chronic Lymphocytic Leukemia (CLL) Patient Monoclonal Antibodies for Chronic Lymphocytic Leukemia (CLL) and Other High-Risk Patients Who Test Positive for COVID-19... March 1, 2021C19 - Updates, COVID-19By Brad Hedrick
Monoclonal Antibodies for Chronic Lymphocytic Leukemia (CLL) and Other High-Risk Patients Who Test Positive for COVID-19 Monoclonal Antibodies for Chronic Lymphocytic Leukemia (CLL) and Other High-Risk Patients Who Test Positive for COVID-19... February 26, 2021C19 - Updates, COVID-19By Brad Hedrick
Chronic Lymphocytic Leukemia (CLL) Patients and Protection against COVID-19: Passive and Active Immunity, Monoclonal Antibodies and Vaccines CLL Meets COVID Vaccines. Dr. Koffman shares what we know, what we don't know and next steps here.... February 25, 2021C19 - Updates, COVID-19, Official Statements and Press ReleasesBy Brad Hedrick
Trials Studying the Safety and Immune Response of Chronic Lymphocytic Leukemia (CLL) Patients Receiving the COVID-19 Vaccines Dr. Brian Koffman provides us with a well-referenced video guide to the appropriate use of various types of face masks... February 12, 2021C19 - Updates, COVID-19, News, News about Clinical TrialsBy Brad Hedrick
Dr. Rick Furman on CLL (chronic lymphocytic leukemia) patients and Vaccinations to Prevent COVID-19 Many of you already know CLL expert Dr. Rick Furman, Director of the CLL Research Center at Weill Cornell Medicine in New York City,... January 25, 2021C19 - Updates, COVID-19By Brad Hedrick
ASH 2020 Update: Anti-SARS-CoV-2 Antibody Response in Patients with Chronic Lymphocytic Leukemia Research pertaining to when CLL meets COVID-19 is only just beginning. There is no doubt that studies will rapidly accelerate... January 4, 20212020 Conferences, C19 - Updates, COVID-19By Brad Hedrick
Update on CALAVI Phase II trials for Acalabrutinib in Patients Hospitalized with Respiratory Symptoms of COVID-19 There has been much excitement about the possibility that BTK inhibitors such as ibrutinib or acalabrutinib might improve outcomes in... January 4, 2021C19 - Updates, Clinical, COVID-19By Brad Hedrick
CLL Society’s Official Statement Concerning SARS-CoV-2 Vaccine in CLL Patients 1/04/2021 CLL Society’s Official Statement Concerning SARS-CoV-2 Vaccine in CLL patients 2/28/2021 We have heard your questions! Should I get the vaccine? Is... January 4, 2021COVID-19, Official Statements and Press ReleasesBy Brad Hedrick
Stop the spread of COVID-19! Urgent Message from Dr. Brian Koffman Stop the spread of COVID-19! "With vaccines on the horizon, we are so close to controlling this pandemic.... December 20, 2020C19 - Updates, COVID-19, SupportBy Brad Hedrick
COVID-19: Dr. Neil Kay on Managing Re-Entry: When Will it be Safe for Patients with CLL? In our interview, my doctor, Dr. John Byrd from The Ohio State University, Columbus, OH, gives his detailed advice for... December 15, 2020COVID-19, COVID-19 Managing Re-EntryBy Brad Hedrick
